Kintegral Advisory’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.29M Sell
17,946
-796
-4% -$147K 0.31% 87
2025
Q4
$3.3M Sell
18,742
-512
-3% -$83.6K 0.28% 93
2025
Q3
$2.7M Sell
19,254
-86
-0.4% -$11.6K 0.23% 108
2025
Q2
$2.43M Sell
19,340
-29
-0.1% -$3.61K 0.22% 111
2025
Q1
$2.65M Sell
19,369
-66
-0.3% -$9.44K 0.27% 101
2024
Q4
$2.97M Sell
19,435
-905
-4% -$153K 0.28% 97
2024
Q3
$3.94M Sell
20,340
-266
-1% -$55.6K 0.36% 86
2024
Q2
$4.78M Buy
20,606
+7,885
+62% +$1.71M 0.46% 61
2024
Q1
$2.74M Sell
12,721
-40
-0.3% -$9.37K 0.27% 96
2023
Q4
$3.3M Sell
12,761
-81
-0.6% -$19.9K 0.37% 81
2023
Q3
$3.3M Sell
12,842
-8
-0.1% -$2.14K 0.41% 70
2023
Q2
$3.66M Hold
12,850
0.43% 70
2023
Q1
$3.57M Sell
12,850
-690
-5% -$191K 0.46% 69
2022
Q4
$3.75M Buy
13,540
+5,262
+64% +$1.49M 0.5% 64
2022
Q3
$2.21M Hold
8,278
0.31% 87
2022
Q2
$1.69M Buy
8,278
+175
+2% +$35.8K 0.22% 110
2022
Q1
$1.71M Buy
8,103
+182
+2% +$39.6K 0.19% 117
2021
Q4
$1.9M Hold
7,921
0.2% 115
2021
Q3
$2.24M Hold
7,921
0.26% 93
2021
Q2
$2.74M Hold
7,921
0.32% 78
2021
Q1
$2.22M Hold
7,921
0.28% 91
2020
Q4
$1.94M Hold
7,921
0.26% 97
2020
Q3
$2.25M Sell
7,921
-255
-3% -$71.1K 0.34% 75
2020
Q2
$2.19M Hold
8,176
0.35% 75
2020
Q1
$2.59M Buy
8,176
+916
+13% +$278K 0.5% 53
2019
Q4
$2.15M Hold
7,260
0.39% 76
2019
Q3
$1.69M Hold
7,260
0.34% 86
2019
Q2
$1.7M Hold
7,260
0.34% 85
2019
Q1
$1.72M Sell
7,260
-463
-6% -$146K 0.36% 83
2018
Q4
$2.32M Buy
+7,723
New +$2.46M 0.69% 37

Other funds holding BIIB